IPCA Laboratories: Target price increased to Rs 1,820

In consolidated financials, IPCA recorded Rs 276.4m as a one-time write-off related to the Pisgah subsidiary. Adjusted for the write-off, the subsidiary performance was largely stable.

from The Financial Express https://ift.tt/3hMsx9u
https://ift.tt/eA8V8J Nomura